S2G Investments — 2017 Investments
3 investments dated 2017 · listed companies and verified rows first · show all
MycoTechnology develops food and beverage ingredients using mushroom mycelial fermentation, creating flavor modulation and sugar-reduction solutions for formulators, chefs, and R&D professionals.
BiotechFoodTechNew MaterialsAurora, US
Brooks Kelly(Director)Alan Hahn(Board Member & Co-Founder)in
BoardPeter Lubar(Director)Scott Horner(Director)inEphraim Lindenbaum(Director)
Board seatSanjeev Krishnan· per SEC Form D
Co-investorsBloom8Cerity Partners VenturesCIBUS ENTERPRISE FUND II LPDAO JonesEvolution VC PartnersGaingels+14 more
Portland, US
Plasse Ken(Executive Officer, Director)
BoardTyler Mayoras(Director)Nicholas Walrod(Director)inChuck Templeton(Director)inMark Shaughnessy(Director)Anthony Arnerich(Director)
Co-investors3x5 PartnersBlueberry VenturesCollaborative Fund
SafeTraces develops technology to measure and verify indoor air quality and ventilation performance, aimed at ensuring air safety in indoor environments.
BiotechCleantechDeep TechHardwareHealthtechPleasanton, US
Ulrike Hodges(Director)Antonios Zografos(Executive Officer, Director)John Kraus(Director)Rob Veres(Director)
Co-investorsAgility CapitalCity LightBungeOmidyar Network
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





__Twitter.png)




